Brainify.AI Company

AI/ML EEG biomarker platform for novel treatment development for depression in women, which increases the likelihood of new drug approval.

Last Funding Type: Pre-Seed
Funding Status: Seed
Headquarters: New York, New York, United States
Founded Date: 2021-02-27
Investor Type: info@brainify.ai
Last Funding Date: 2023-01-10
Total Funding: 1600000
Technology: ['BioTech & HealthTech']
Employee Number: 11-50
Industry: NeuroTech